Results 261 to 270 of about 226,665 (388)

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

open access: yesCancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang   +18 more
wiley   +1 more source

Sex hormones and allergies: exploring the gender differences in immune responses. [PDF]

open access: yesFront Allergy
Gutiérrez-Brito JA   +5 more
europepmc   +1 more source

The Estrogenic Activity of Legume, Grass, and Corn Silage

open access: bronze, 1956
P. J. Pieterse, F. N. Andrews
openalex   +1 more source

Home - About - Disclaimer - Privacy